Vendor, Baltimore, MD
Kydes Pharmaceuticals LLC
UEI GJF6NJHCKQN8, CAGE 675F0
1 award and -$48,000 obligated between September 11, 2024 and September 11, 2024, 0% under full and open competition, against 1.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N94020P00414Purchase Order, September 11, 2024, Competed Under SAP, 1 offers | National Institutes of Health NichdNational Institutes of Health | Niddk to Acquire Process of Tablet DevelopmentNAICS 541380, PSC Q301 | -$48,000 |
- Places of performance
- Maryland
- Product and service codes
- Q301 Reference Laboratory Testing
- Transactions
- 1 across 1 awards